- ►nejm.org C Salvarani, F Cantini, GG Hunder - The Lancet, 2008 - Elsevier Polymyalgia rheumatica and giant-cell arteritis are closely related disorders
that affect people of middle age and older. They frequently occur together. Both
are syndromes of unknown cause, but genetic and environmental factors might ... Cited by 391 - Related articles - BL Direct - All 28 versions
DE Furst, FC Breedveld, JR Kalden, JS … - British Medical Journal, 2007 - ard.bmj.com As in previous years, the consensus group to consider the use of biological
agents was constituted by rheumatologists from the universities of Erlangen,
Leiden and Vienna in Europe in cooperation with other universities in the ... Cited by 79 - Related articles - BL Direct - All 5 versions
DE Furst, EC Keystone, B Kirkham, R … - British Medical Journal, 2008 - ard.bmj.com As in previous years, the consensus group to consider the use of biological
agents in the treatment of rheumatic diseases met during the 10th Annual
Workshop on Advances in Targeted Therapies. The group consisted of ... Cited by 29 - Related articles - All 6 versions
VM Martinez-Taboada, V Rodriguez-Valverde, … - British Medical Journal, 2008 - ard.bmj.com Results: Baseline characteristics were similar in the two groups, although
patients in the etanercept group showed higher levels of basal glycaemia (p =
0.02) and a higher erythrocyte sedimentation rate (ESR) (p = 0.01). After ... Cited by 12 - Related articles - BL Direct - All 3 versions
C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, … - British Medical Journal, 2009 - ard.bmj.com Methods: An expert group (10 rheumatologists, 3 nephrologists, 2 immunolgists, 2
internists representing 8 European countries and the USA, a clinical
epidemiologist and a representative from a drug regulatory agency) ... Cited by 10 - Related articles - All 3 versions
HL Gornik, MA Creager - Circulation, 2008 - Am Heart Assoc Aortitis is the all-encompassing term ascribed to inflammation of the aorta. The
most common causes of aortitis are the large-vessel vasculitides giant cell
arteritis (GCA) and Takayasu arteritis, although it also is associated with ... Cited by 8 - Related articles - All 4 versions
KJ Warrington, EL Matteson - Clinical and experimental rheumatology, 2007 - clinexprheumatol.org Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota,
USA. Kenneth J. Warrington, MD; Eric L. Matteson, MD, MPH. Please address
correspondence to: Kenneth J. Warrington MD, Mayo Clinic, Rheumatology E15, ... Cited by 6 - Related articles - View as HTML - BL Direct - All 3 versions
N Pipitone, C Salvarani - Current opinion in rheumatology, 2008 - journals.lww.com Recent findings: An initial dose of 40-60 mg/day of prednisone is usually
adequate. Patients at risk of developing ischemic complications require dosages
of around 1 mg/kg/day, whereas pulse glucocorticoid therapy is no more ... Cited by 7 - Related articles - BL Direct - All 7 versions
F Tato, U Hoffmann - Vascular Medicine, 2008 - vmj.sagepub.com Abstract: Giant cell arterits (GCA) is increasingly being recognized as a
systemic vas- cular disease, not confined to the cranial arteries.
Epidemiological studies have shown that almost one-third of the patients ... Cited by 5 - Related articles - BL Direct - All 3 versions
JK Hall, LJ Balcer - Current Treatment Options in Neurology, 2004 - Springer Introduction Giant cell arteritis (GCA) is a vasculitis of medium and large
vessels, and rarely affects people under the age of 50. The incidence increases
with age and has been observed to increase approximately 13-fold between ... Cited by 5 - Related articles - BL Direct - All 6 versions
